Literature DB >> 27825584

Autism in patients with propionic acidemia.

Peter Witters1, Eric Debbold2, Kea Crivelly2, Kristel Vande Kerckhove1, Karen Corthouts1, Brett Debbold2, Hans Andersson2, Lena Vannieuwenborg3, Sam Geuens3, Matthias Baumgartner4, Tamas Kozicz5, Lisa Settles6, Eva Morava7.   

Abstract

Certain inborn errors of metabolism have been suggested to increase the risk of autistic behavior. In an animal model, propionic acid ingestion triggered abnormal behavior resembling autism. So far only a few cases were reported with propionic acidemia and autistic features. From a series of twelve consecutively diagnosed cases with propionic acidemia, we report on eight patients with autistic features. The patients were followed 2-4 times a year and underwent regular clinical, dietary and laboratory investigations. Psychological evaluation was performed every second to fourth year. All patients were compliant with the standard diet and carnitine supplementation. None of the patients had frequent metabolic decompensations. From the metabolic factors known to impact neuropsychological outcome we detected chronically decreased valine levels and altered valine to leucine ratios in five out of the eight patients. Recurrent lactic acid elevations were present in six out of the eight patients. Five of the eight patients were diagnosed with Autism Spectrum Disorder, four of them had pathogenic variants in PCCB. Disorder according to DSM-IV and/or DSM-5 criteria. One of the patients diagnosed with propionic acidemia by newborn screening had the most significant behavioral features and another was diagnosed with Autism Spectrum Disorder prior to propionic acidemia. We hypothesize that chronic suboptimal intracellular metabolic balance may be responsible for the increased risk for autistic features in propionic acidemia. We propose that patients diagnosed with propionic acidemia should be screened for Autism Spectrum Disorder.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ASD; Autistic; Dietary therapy; Intellectual disability; Lactic acid; Leucine; Mitochondria; Propionic acid; Valine

Mesh:

Substances:

Year:  2016        PMID: 27825584     DOI: 10.1016/j.ymgme.2016.10.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  18 in total

1.  A Subset of Patients With Autism Spectrum Disorders Show a Distinctive Metabolic Profile by Dried Blood Spot Analyses.

Authors:  Rita Barone; Salvatore Alaimo; Marianna Messina; Alfredo Pulvirenti; Jean Bastin; Alfredo Ferro; Richard E Frye; Renata Rizzo
Journal:  Front Psychiatry       Date:  2018-12-07       Impact factor: 4.157

2.  Impaired Spatial Cognition in Adult Rats Treated with Multiple Intracerebroventricular (ICV) Infusions of the Enteric Bacterial Metabolite, Propionic Acid, and Return to Baseline After 1 Week of No Treatment: Contribution to a Rodent Model of ASD.

Authors:  Jennifer R Mepham; Francis H Boon; Kelly A Foley; Donald P Cain; Derrick F MacFabe; Klaus-Peter Ossenkopp
Journal:  Neurotox Res       Date:  2019-03-08       Impact factor: 3.911

Review 3.  Propionyl-CoA carboxylase - A review.

Authors:  Parith Wongkittichote; Nicholas Ah Mew; Kimberly A Chapman
Journal:  Mol Genet Metab       Date:  2017-10-07       Impact factor: 4.797

Review 4.  The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders.

Authors:  Roberto Coccurello; Maria Cristina Marrone; Mauro Maccarrone
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

Review 5.  Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Afaf El-Ansary; Mona A El-Bana; Maryam Dadar; Jan Aaseth; Maha Hemimi; Joško Osredkar; Salvatore Chirumbolo
Journal:  J Mol Neurosci       Date:  2018-10-24       Impact factor: 3.444

6.  Autism spectrum disorders in propionic acidemia patients.

Authors:  Caroline Dejean de la Bâtie; Valérie Barbier; Célina Roda; Anaïs Brassier; Jean-Baptiste Arnoux; Vassili Valayannopoulos; Anne-Sophie Guemann; Clément Pontoizeau; Stéphanie Gobin; Florence Habarou; Florence Lacaille; Jean-Paul Bonnefont; Pierre Canouï; Chris Ottolenghi; Pascale De Lonlay; Lisa Ouss
Journal:  J Inherit Metab Dis       Date:  2017-08-30       Impact factor: 4.982

Review 7.  Organic acidurias in adults: late complications and management.

Authors:  Ali Tunç Tuncel; Nikolas Boy; Marina A Morath; Friederike Hörster; Ulrike Mütze; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2018-01-15       Impact factor: 4.982

Review 8.  Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.

Authors:  Nishitha R Pillai; Bridget M Stroup; Anna Poliner; Linda Rossetti; Brandy Rawls; Brian J Shayota; Claudia Soler-Alfonso; Hari Priya Tunuguntala; John Goss; William Craigen; Fernando Scaglia; V Reid Sutton; Ryan Wallace Himes; Lindsay C Burrage
Journal:  Mol Genet Metab       Date:  2019-11-07       Impact factor: 4.797

9.  Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision.

Authors:  Patrick Forny; Friederike Hörster; Diana Ballhausen; Anupam Chakrapani; Kimberly A Chapman; Carlo Dionisi-Vici; Marjorie Dixon; Sarah C Grünert; Stephanie Grunewald; Goknur Haliloglu; Michel Hochuli; Tomas Honzik; Daniela Karall; Diego Martinelli; Femke Molema; Jörn Oliver Sass; Sabine Scholl-Bürgi; Galit Tal; Monique Williams; Martina Huemer; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2021-03-09       Impact factor: 4.750

10.  Hippocampal Metabolite Profiles in Two Rat Models of Autism: NMR-Based Metabolomics Studies.

Authors:  B Toczylowska; E Zieminska; P Senator; J W Lazarewicz
Journal:  Mol Neurobiol       Date:  2020-05-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.